Concepedia

Uwe Hehnke

UH

13

Publications

454

Citations

11

H-Index

1993

Active since

Affiliations

Boehringer Ingelheim (Germany)(Current)

Boehringer Ingelheim (United States)

Boehringer Ingelheim (United Kingdom)

Helsinki University Hospital

Dallas Diabetes Research Center

Uwe Hehnke is an author at Boehringer Ingelheim (Germany) specializing in medicine, metabolic syndrome, and geriatrics.

Top concepts

Publications per year

1993–2018

13

Publications

13

Kidney Disease End Points in a Pooled Analysis of Individual Patient–Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 Diabetes

Mark E. Cooper, Vlado Perkovic, Janet B. McGill et al. · American Journal of Kidney Diseases · 2015 · 110 citations · Full text

Glycyrrhizin in patients who failed previous interferon alpha‐based therapies: biochemical and histological effects after 52 weeks

Michael P. Manns, Heiner Wedemeyer, A. Singer et al. · Journal of Viral Hepatitis · 2012 · 73 citations · Full text

Multicenter Comparison of Micronized Fenofibrate and Simvastatin in Patients with Primary Type IIA or IIB Hyperlipoproteinemia

Armin Steinmetz, Thomas Schwartz, Uwe Hehnke et al. · Journal of Cardiovascular Pharmacology · 1996 · 53 citations

Video Rating Analysis of Effect of Maprotiline in Patients with Dementia and Depression

A. Fuchs, Uwe Hehnke, C. Erhart et al. · Pharmacopsychiatry · 1993 · 48 citations

, , +17

Impact of empagliflozin on blood pressure in dipper and non‐dipper patients with type 2 diabetes mellitus and hypertension

Robert Ćhilton, Ilkka Tikkanen, Uwe Hehnke et al. · Diabetes Obesity and Metabolism · 2017 · 46 citations

Rows per page

1–5 of 13